Jordan A Woolum1, Erin L Abner2, Andrew Kelly3, Melissa L Thompson Bastin1,4, Peter E Morris5, Alexander H Flannery1,4. 1. Department of Pharmacy Services, University of Kentucky HealthCare, Lexington, KY. 2. University of Kentucky College of Public Health, Lexington, KY. 3. Center for Health Services Research, University of Kentucky HealthCare, Lexington, KY. 4. Department of Pharmacy Practice and Science, University of Kentucky College of Pharmacy, Lexington, KY. 5. Division of Pulmonary, Critical Care, and Sleep Medicine, University of Kentucky College of Medicine, Lexington, KY.
Abstract
OBJECTIVES: Mounting evidence has shown that critically ill patients are commonly thiamine deficient. We sought to test the hypothesis that critically ill patients with septic shock exposed to thiamine would demonstrate improved lactate clearance and more favorable clinical outcomes compared with those not receiving thiamine. DESIGN: Retrospective, single-center, matched cohort study. SETTING: Tertiary care academic medical center. PATIENTS: Adult patients admitted with an International Classification of Diseases, 9th Edition, or International Classification of Diseases, 10th Edition, diagnosis code of septic shock to either the medicine or surgery ICU. INTERVENTIONS: None. MEASUREMENTS AND MAIN RESULTS: Patients who received IV thiamine supplementation within 24 hours of hospital admission were identified and compared with a matched cohort of patients not receiving thiamine. The primary objective was to determine if thiamine administration was associated with a reduced time to lactate clearance in septic shock. Secondary outcomes included 28-day mortality, acute kidney injury, and need for renal replacement therapy, and vasopressor and mechanical ventilation-free days. Two-thousand two-hundred seventy-two patients were screened, of whom 1,049 were eligible. The study consisted of 123 thiamine-treated patients matched with 246 patients who did not receive thiamine. Based on the Fine-Gray survival model, treatment with thiamine was associated with an improved likelihood of lactate clearance (subdistribution hazard ratio, 1.307; 95% CI, 1.002-1.704). Thiamine administration was also associated with a reduction in 28-day mortality (hazard ratio, 0.666; 95% CI, 0.490-0.905). There were no differences in any secondary outcomes. CONCLUSIONS: Thiamine administration within 24 hours of admission in patients presenting with septic shock was associated with improved lactate clearance and a reduction in 28-day mortality compared with matched controls.
OBJECTIVES: Mounting evidence has shown that critically illpatients are commonly thiamine deficient. We sought to test the hypothesis that critically illpatients with septic shock exposed to thiamine would demonstrate improved lactate clearance and more favorable clinical outcomes compared with those not receiving thiamine. DESIGN: Retrospective, single-center, matched cohort study. SETTING: Tertiary care academic medical center. PATIENTS: Adult patients admitted with an International Classification of Diseases, 9th Edition, or International Classification of Diseases, 10th Edition, diagnosis code of septic shock to either the medicine or surgery ICU. INTERVENTIONS: None. MEASUREMENTS AND MAIN RESULTS:Patients who received IV thiamine supplementation within 24 hours of hospital admission were identified and compared with a matched cohort of patients not receiving thiamine. The primary objective was to determine if thiamine administration was associated with a reduced time to lactate clearance in septic shock. Secondary outcomes included 28-day mortality, acute kidney injury, and need for renal replacement therapy, and vasopressor and mechanical ventilation-free days. Two-thousand two-hundred seventy-two patients were screened, of whom 1,049 were eligible. The study consisted of 123 thiamine-treated patients matched with 246 patients who did not receive thiamine. Based on the Fine-Gray survival model, treatment with thiamine was associated with an improved likelihood of lactate clearance (subdistribution hazard ratio, 1.307; 95% CI, 1.002-1.704). Thiamine administration was also associated with a reduction in 28-day mortality (hazard ratio, 0.666; 95% CI, 0.490-0.905). There were no differences in any secondary outcomes. CONCLUSIONS:Thiamine administration within 24 hours of admission in patients presenting with septic shock was associated with improved lactate clearance and a reduction in 28-day mortality compared with matched controls.
Authors: Scott L Weiss; Bridget Blowey; Luke Keele; Rebecca Ganetzky; Chaya N Murali; Julie C Fitzgerald; Robert M Sutton; Robert A Berg Journal: Pediatr Crit Care Med Date: 2019-09 Impact factor: 3.624
Authors: Ruben Manuel Luciano Colunga Biancatelli; Max Berrill; Yassen H Mohammed; Paul E Marik Journal: J Thorac Dis Date: 2020-02 Impact factor: 2.895
Authors: Tomoko Fujii; Nora Luethi; Paul J Young; Daniel R Frei; Glenn M Eastwood; Craig J French; Adam M Deane; Yahya Shehabi; Ludhmila A Hajjar; Gisele Oliveira; Andrew A Udy; Neil Orford; Samantha J Edney; Anna L Hunt; Harriet L Judd; Laurent Bitker; Luca Cioccari; Thummaporn Naorungroj; Fumitaka Yanase; Samantha Bates; Forbes McGain; Elizabeth P Hudson; Wisam Al-Bassam; Dhiraj Bhatia Dwivedi; Chloe Peppin; Phoebe McCracken; Judit Orosz; Michael Bailey; Rinaldo Bellomo Journal: JAMA Date: 2020-02-04 Impact factor: 56.272